Key facts
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Zura Bio Limited Class A Ordinary Shares (ZURA).
- Disclosed ownership: 4.4%.
- Date of event: 31 Mar 2026.
GREAT POINT PARTNERS LLC - 31 Mar 2026 SCHEDULE 13G/A Report for Zura Bio Limited Class A Ordinary Shares (ZURA)
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Symbol
- ZURA
- Shares outstanding
- 94,953,378 shares
- Disclosed Ownership
- 4,215,930 shares
- Ownership
- 4.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 08:54:46 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Key filing fact
GREAT POINT PARTNERS LLC disclosed 4.4% ownership in Zura Bio Limited Class A Ordinary Shares (ZURA) on 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 15 May 2026, 08:54.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 4.4% | 4,215,930 | 0 | 4,215,930 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 4.4% | 4,215,930 | 0 | 4,215,930 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 4.4% | 4,215,930 | 0 | 4,215,930 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |
CIK / CUSIP context first